<unk>  (also known as Mildronate, THP, MET-88, Mildronāts or Quaterine) is a clinically used anti-ischemic drug that is currently manufactured and marketed by Grindeks, a pharmaceutical company based in Latvia.  It is used in Lithuania and the Russian Federation, but is not approved by the Food and Drug Administration for use in the United States.
Meldonium
Oogonium
Isavuconazonium
Benzethonium chloride
Benzalkonium chloride
Ambenonium
Edrophonium
Methyl tert-butyl ether